These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19741634)

  • 21. Conclusions: promoting biotechnology innovation in developing countries.
    Thorsteinsdóttir H; Quach U; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl(Suppl 12):DC48-52. PubMed ID: 15583685
    [No Abstract]   [Full Text] [Related]  

  • 22. What Brexit means for biotech.
    Nat Biotechnol; 2016 Aug; 34(8):785. PubMed ID: 27504756
    [No Abstract]   [Full Text] [Related]  

  • 23. China Biotech Scene, U.S. Collaborations Grow.
    Cancer Discov; 2020 Mar; 10(3):336. PubMed ID: 32024633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rising to the Kyoto challenge: is the response of Canadian industry adequate?
    Takahashi T; Nakamura M; van Kooten GC; Vertinsky I
    J Environ Manage; 2001 Oct; 63(2):149-61. PubMed ID: 11721595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug firms 'waging war' on the developing world.
    Munro R
    Nurs Times; 2001 Feb 22-28; 97(8):10. PubMed ID: 11954205
    [No Abstract]   [Full Text] [Related]  

  • 26. A report from Biopharm America 2013 - sixth Annual International Partnering Conference (September 16-19, 2013 - Boston, Massachusetts, USA).
    Johnston D; Osborne R; Kuhrt K
    Drugs Today (Barc); 2013 Nov; 49(11):739-44. PubMed ID: 24308019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indian biotechnology--rapidly evolving and industry led.
    Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682
    [No Abstract]   [Full Text] [Related]  

  • 28. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

  • 29. Perfect partnering.
    Moscho A; Leiter JM
    Nat Biotechnol; 2001 Jul; 19 Suppl():BE21-2. PubMed ID: 11433244
    [No Abstract]   [Full Text] [Related]  

  • 30. Benefits of biotech clusters questioned.
    Sheridan C
    Nat Biotechnol; 2003 Nov; 21(11):1258-9. PubMed ID: 14595343
    [No Abstract]   [Full Text] [Related]  

  • 31. A very firm handshake: biotech's growing negotiating power.
    Thiel KA
    Nat Biotechnol; 2005 Oct; 23(10):1221-6. PubMed ID: 16211058
    [No Abstract]   [Full Text] [Related]  

  • 32. Biopharma business models in Canada.
    March-Chordà I; Yagüe-Perales RM
    Drug Discov Today; 2011 Aug; 16(15-16):654-8. PubMed ID: 21708279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partnerships between patients, medicine, and the biotechnology industry.
    Kent A; Tambuyzer E
    Nat Biotechnol; 1999 Oct; 17(10):935. PubMed ID: 10504676
    [No Abstract]   [Full Text] [Related]  

  • 34. Decentralization key to ScanBalt.
    Frank P
    Nat Biotechnol; 2005 Oct; 23(10):1211. PubMed ID: 16211052
    [No Abstract]   [Full Text] [Related]  

  • 35. Reforming Canada's Access to Medicines Regime.
    Elliott R
    CMAJ; 2007 Jul; 177(3):270-1. PubMed ID: 17664453
    [No Abstract]   [Full Text] [Related]  

  • 36. Reforming Canada's Access to Medicines Regime.
    Esmail LC
    CMAJ; 2007 Jul; 177(3):270. PubMed ID: 17664454
    [No Abstract]   [Full Text] [Related]  

  • 37. Millennium and Aventis in unique pact.
    Fletcher L
    Nat Biotechnol; 2000 Aug; 18(8):817. PubMed ID: 10932140
    [No Abstract]   [Full Text] [Related]  

  • 38. Academic partnerships 2015.
    Huggett B
    Nat Biotechnol; 2016 Apr; 34(4):372. PubMed ID: 27054985
    [No Abstract]   [Full Text] [Related]  

  • 39. South-South entrepreneurial collaboration in health biotech.
    Thorsteinsdóttir H; Melon CC; Ray M; Chakkalackal S; Li M; Cooper JE; Chadder J; Saenz TW; Paula MC; Ke W; Li L; Madkour MA; Aly S; El-Nikhely N; Chaturvedi S; Konde V; Daar AS; Singer PA
    Nat Biotechnol; 2010 May; 28(5):407-16. PubMed ID: 20458300
    [No Abstract]   [Full Text] [Related]  

  • 40. Metrics survey of industry-sponsored clinical trials in Canada and comparator jurisdictions between 2005 and 2010.
    Leclerc JM; Laberge N; Marion J
    Healthc Policy; 2012 Nov; 8(2):88-104. PubMed ID: 23968618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.